Cureus Launches Medical Publishing Competition Designed to Accelerate Research and Awareness of Epidermal Skin Grafting

Share Article

Competition Calls for Original Research Highlighting Experiences and Outcomes from the Use of Novel Epidermal Grafting Technique

With these novel methods, physicians can now harvest epidermal grafts without creating a new wound to repair another. Further, patients can avoid a complex surgical procedure.

The Cureus Journal of Medical Science is collaborating with Acelity™, a global advanced wound care and regenerative medicine company, to inspire continued study and greater clinical awareness of epidermal harvesting for autologous skin grafting to manage acute and chronic skin wounds. Today they launch a medical publishing competition calling on physicians to submit original research highlighting the clinical and procedural experiences, patient outcomes, and/or economic advantages of this advance in wound care.

Unlike traditional autologous skin grafting that requires the use of large areas of skin from the donor site and is harvested during a surgical procedure with anesthesia, epidermal grafting offers a simplified and minimally invasive option for wound management. With epidermal skin harvesting, there is minimal scarring and pain at the donor site.

“With these novel methods, physicians can now harvest epidermal grafts without creating a new wound to repair another. Further, patients can avoid a complex surgical procedure,” said John Adler, M.D., founder and CEO of Cureus and professor of neurosurgery at Stanford University. “Cureus is very pleased to partner with Acelity to further the medical and scientific discovery for this medical procedure.”

To ensure full scientific integrity and objectivity, all submissions will be peer-reviewed prior to Cureus publication. Following publication, all articles will be made accessible for search and free full-article download via PubMed Central - the National Institute of Health (NIH) -hosted digital search engine for full-text biomedical literature.

Monetary prizes will be awarded to the authors of the three articles receiving the highest Cureus SIQ (Scholarly Impact Quotient) score. SIQ is Cureus’ unique crowdsourced post-publication review that allows the clinical community-at-large to review and score published medical literature. Reviewers can assign scores on article criteria including study design and methods, clarity and rationale, novelty of conclusions, etc. The resulting community SIQ scores allow researchers to quickly assess literature quality in a manner similar to that of Amazon customer reviews or Yelp restaurant reviews.

Article submission is entirely free. Eligible articles must be submitted for editorial and peer review by Thursday, May 26, 2016. More information regarding this publishing competition can be found at http://www.cureus.com/competitions/kci-epidermalgrafting.

About Cureus

The Cureus Journal of Medical Science is a no-cost, peer-reviewed online medical publishing platform that leverages a unique crowdsourced, post-publication review process. Relying on the collective intelligence of its clinical community, Cureus enables faster publication, greater access, and ultimately, better research. Visit http://www.cureus.com for more information.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mark Arnold
Cureus
+1 415-533-4743
Email >
@CureusInc
Follow >
Visit website